Catch up on stories from the past week (and beyond) at the Slashdot story archive

 



Forgot your password?
typodupeerror
Check out the new SourceForge HTML5 internet speed test! No Flash necessary and runs on all devices. ×
Medicine

Majority of Landmark Cancer Studies Cannot Be Replicated 233

New submitter Beeftopia writes with perhaps distressing news about cancer research. From the article: "During a decade as head of global cancer research at Amgen, C. Glenn Begley identified 53 'landmark' publications — papers in top journals, from reputable labs — for his team to reproduce. Begley sought to double-check the findings before trying to build on them for drug development. Result: 47 of the 53 could not be replicated. He described his findings in a commentary piece published on Wednesday in the journal Nature (paywalled) . ... But they and others fear the phenomenon is the product of a skewed system of incentives that has academics cutting corners to further their careers." As is the fashion at Nature, you can only read the actual article if you are a subscriber or want to fork over $32. Anyone with access care to provide more insight? Update: 04/06 14:00 GMT by U L : Naffer pointed us toward informative commentary in Pipeline. Thanks!
This discussion has been archived. No new comments can be posted.

Majority of Landmark Cancer Studies Cannot Be Replicated

Comments Filter:

"Tell the truth and run." -- Yugoslav proverb

Working...